|
Introduction
I.V. Carrier Solutions
Infusion Admixture Ranges
Miscellaneous Admixtures
Emergency Injections
Example Protocol Based on
ACAM Protocol
Footnotes
Introduction
This brief compendium of
medications is not intended to replace or supercede the American College of
Advancement in Medicine (ACAM) or Great Lakes College of Clinical Medicine (GLCCM)
Protocol for EDTA Chelation Therapy. This compendium is our attempt to aid the
physician who is already familiar with this protocol but who needs a ready
reference to rapidly correlate a patient's unique needs to the ACAM/GLCCM
Protocol.
The medications used in EDTA Chelation Therapy may vary by type and dose
depending upon the individual needs of the patient. This compendium is designed
to be a useful summation of the "Treatment Procedures" section of the ACAM/GLCCM
Protocol.
Some of the information contained herein was obtained from the ACAM Workshops on
EDTA Chelation Therapy. While this information is not covered by the protocol
its inclusion here was deemed beneficial as background material. All information
derived from the ACAM Workshop is clearly labeled as such.
I.V.
Carrier Solutions
The chelating physician may use one of several I.V. Solutions. Each I.V.
solution has it’s own unique benefits and risks.
Sterile Water for Injection is beneficial as a carrier
solution because of it’s zero osmolarity. Further, Sterile Water for Injection
does not contain Sodium, Dextrose or Lactate molecules so once isotonicity is
achieved the sterile water will have minimal effect on the patient. The
combination of Sterile Water for Injection with several admixtures (especially
Ascorbic Acid) generally results in an I.V. solution which approximates isotonic
conditions. The risk of Sterile Water for Injection is that without admixtures,
it is hypotonic and hemolytic. No injection of sterile water is to be given
until it is made approximately isotonic by the addition of appropriate solute.
0.45% Sodium Chloride Injection
is beneficial as a
carrier solution because of it’s low osmotic pressure. The combination of 0.45%
Sodium Chloride Injection with several admixtures generally results in a
hypertonic solution. The risk of 0.45% Sodium Chloride Injection is the added
Sodium content in the final solution.2
5% Dextrose in Water for Injection
is beneficial as a carrier solution because of the calories it provides during
the treatment. Additionally, unlike Sodium Chloride or Lactated Ringer’s
Injections it does not contain Sodium. The combination of 5% Dextrose in Water
with just a few admixtures generally results in a hypertonic solution. The risk
of 5% Dextrose in Water is for the diabetic patient which may not tolerate the
added dextrose well. It is generally believed however, that a 5% Dextrose
solution given over four hours does not maintain a significant risk to diabetic
patients.3
0.9% Sodium Chloride Injection
is beneficial as a
carrier solution because it is isotonic and closely aligned with intra-cellular
fluids. The combination of 0.9% Sodium Chloride with just a few admixtures
results in a significant hypertonic solution. The risk of 0.9% Sodium Chloride
is the added Sodium content in the final solution.4
Lactated Ringers Injection
is beneficial because of
its own mild chelating properties. The risk of Lactated Ringer’s Injection is
that it is slightly hypertonic and when combined with admixtures will generally
become significantly hypertonic. Additionally, Lactated Ringer's Injection
contains three millimoles of Calcium which consumes 34% of the EDTA activity.
Lactated Ringer’s Injection adds to the Sodium content of the final solution.5
Top
Infusion Admixture Ranges
The following admixtures
are added to the I.V. carrier solution prior to administration.
Admixtures shown in BLUE are currently available from Compounding
Pharmacies
|
DESCRIPTION |
HOW SUPPLIED |
DOSE PER CHELATION |
ADMIXTURE RANGE |
|
Edetate Disodium |
150mg/mL
20mL SD vial |
0.5 to 5 grams (50mg/kg of lean body weight for patients with normal renal
function)6 |
3.3 to 33.3mL |
|
Magnesium Chloride |
200mg/mL
50mL MD vial |
9mL per 20mL EDTA |
To 15mL |
|
OR |
|
|
|
|
Magnesium Sulfate 50% |
500mg/mL
50mL SD vial |
4.5mL per 20mL EDTA |
To 7.5mL |
|
Lidocaine 2% |
20mg/mL
5mL SD vial |
100 to 200mg |
5 to 10mL |
|
OR |
|
|
|
|
Procaine 2% |
20mg/mL
30mL MD vial |
100 to 200mg |
5 to 10mL |
|
Heparin |
5,000units/mL
10mL MD vial
(SD available) |
1,000 to 5,000 units |
1 to 5mL |
|
Ascorbic Acid w/EDTA7 |
500mg/mL
50mL SD vial |
4 to 20 grams |
8 to 40mL |
|
Potassium Chloride |
2mEq/mL
30mL MD vial
(SD available) |
2mEq/mL |
1mL |
|
Pyridoxine [B-6] |
100mg/mL
30mL MD vial |
100mg |
1mL |
|
Thiamine [B-1] |
100mg/mL |
100mg |
1mL |
|
Sodium Bicarbonate 8.4% |
1mEq/mL
50mL SD vial |
1mEq/300mg EDTA |
To 16.7mL |
|
Dexpanthenol [B-5] |
250mg/mL
30mL MD vial |
250mg to 500mg |
1mL |
Top
Miscellaneous Admixtures
The following injections
are approved for admixture status for EDTA Chelation Therapy but are less
important. Their use varies with physician preference.
|
DESCRIPTION |
HOW SUPPLIED |
DOSE PER CHELATION |
ADMIXTURE RANGE |
|
B-Complex 100 |
30mL MD vial |
1mL |
1mL |
|
B-Complex with C and
B-12 |
10mL MD covial |
1mL |
1mL |
|
Cyanocobalamin |
1,000mcg/mL
30mL MD vials |
1,000mcg |
1mL |
|
Hydroxocobalamin [B-12] |
1,000mcg/mL
30mL MD vial |
1,000mcg |
1mL |
Top
Emergency Injections
for EDTA Chelation Therapy
The following injectables
should be on hand (in addition to a crash cart) for emergency use if needed.
|
DESCRIPTION |
HOW SUPPLIED |
DOSE PER EMERGENCY |
INJECTION RANGE |
|
Calcium Gluconate 10% |
100mg/mL
10mL SD vial |
1 to 2
grams |
10 to
20mL |
|
Dextrose 50% |
500mg/mL
50mL SD vial |
10 grams |
20mL |
Example Protocol Based on
the ACAM Protocol
|
DESCRIPTION |
Potency / mL |
VOLUME |
| Sterile
Water for Injection |
|
500mL |
| Edetate
Disodium |
150mg |
20mL |
| Ascorbic
Acid w/EDTA |
500mg |
15mL |
|
Magnesium Chloride |
200mg |
9mL |
| Sodium
Bicarbonate 8.4% |
1mEq/mL |
10mL |
| Heparin |
5,000
units |
0.5mL |
| Procaine
2% |
20mg |
5mL |
|
Dexpanthenol |
250mg |
1mL |
|
Pyridoxine |
100mg |
1mL |
| Thiamine |
100mg |
1mL |
|
Potassium Chloride |
2mEq |
1mL |
Footnotes:
1. A
careful review of this protocol should be made before attempting this therapy.
Please write or call the American College of Advancement in Medicine (23121
Verdugo Drive, Suite 204 Laguna Hills, California 92653 (714) 583-7666 (800)
532-3688) for a complete protocol.
2. ACAM Chelation
Therapy Workshop. Each 100mL of 0.45% Sodium Chloride for Injection contains
0.45grams of Sodium Chloride.
3. ACAM Chelation
Therapy Workshop. There are 85 calories in a 500mL solution of 5% Dextrose in
Water for Injection. This equates to 28.3 calories per hour, over a three hour
period. The maximum rate at which dextrose can be infused without producing
glycosuria is 0.5g/kg/hr. About 95% is retained when infused at 0.8g/kg/hr.
4. ACAM Chelation
Therapy Workshop. Each 100mL of 0.9% Sodium Chloride for Injection contains
0.90 grams of Sodium Chloride.
5. ACAM Chelation
Therapy Workshop. Each 100mL of Lactated Ringer's Injection contains 0.60grams
of Sodium Chloride.
6. If creatinine
clearance is less than 100mL/min, the dose based on body weight is reduced.
Please see ACAM /GLCCM Protocol.
7. Recommended in ACAM
protocol as "better tolerated" than other types of Ascorbic Acid.
Additionally, Ascorbic Acid w/EDTA has a lower osmotic pressure than Ascorbic
Acid w/Monothioglycerol.
|